Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.

Tajima K, Kohno K, Shiono Y, Suzuki I, Kato Y, Hiroshima Y, Yamamoto M, Ohtake H, Iwaba A, Yamakawa M, Kato T.

Int J Clin Exp Pathol. 2013;6(3):536-42. Epub 2013 Feb 15.

2.

The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.

Mitsumoto F, Murata M, Ura K, Takayama K, Hiramine S, Shimizu M, Toyoda K, Ogawa E, Furusyo N, Hayashi J.

J Infect Chemother. 2015 Apr;21(4):264-71. doi: 10.1016/j.jiac.2014.12.003. Epub 2014 Dec 18.

PMID:
25596071
3.

Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.

Coffin CS, Osiowy C, Myers RP, Gill MJ.

J Clin Virol. 2013 Jun;57(2):103-8. doi: 10.1016/j.jcv.2013.02.004. Epub 2013 Mar 1.

PMID:
23465393
4.

HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.

Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, Sigaloff KC, Hoepelman AI, Stevens WS, Rinke de Wit TF; PharmAccess African Studies to Evaluate Resistance (PASER).

J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):174-82. doi: 10.1097/QAI.0b013e3182a60f7d.

PMID:
23892239
5.

[A case of hepatitis B virus/human immunodeficiency virus coinfection in a patient who achived hepatitis B surface antigen seroclearance after interferon therapy followed by antiretroviral therapy without developing immune reconstitution inflammatory syndrome].

Mitsumoto F, Murata M, Ikezaki H, Ogawa E, Taniai H, Toyoda K, Otaguro S, Kainuma M, Okada K, Furusyo N, Hayashi J.

Kansenshogaku Zasshi. 2012 Nov;86(6):763-7. Japanese.

PMID:
23367852
6.

Hepatitis B immune reconstitution syndrome in a patient with HIV infection.

John MA, Gosnell BI, Manzini TC, Ramdial P, Moosa MS.

Int J STD AIDS. 2016 Oct;27(12):1126-1129. Epub 2016 Jan 13.

PMID:
26769756
7.
8.

Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.

Maida I, Ríos MJ, Pérez-Saleme L, Ramos B, Soriano V, Pegram PS, Mura MS, Sánchez-Margalet V, Saldívar-Cornejo I, Wilkin A, Babudieri S, Núñez M.

AIDS Res Hum Retroviruses. 2008 May;24(5):679-83. doi: 10.1089/aid.2007.0240.

PMID:
18462085
9.

Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.

Sheng WH, Hung CC, Chang SY, Liu CJ, Chen MY, Hsieh SM, Kao JH, Chen PJ, Chang SC.

Clin Infect Dis. 2012 Feb 15;54(4):548-55. doi: 10.1093/cid/cir851. Epub 2011 Dec 7.

PMID:
22156858
10.

Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with a liver biopsy.

Mitsumoto F, Murata M, Kato Y, Ura K, Takayama K, Hiramine S, Ikezaki H, Shimizu M, Toyoda K, Ogawa E, Aishima S, Furusyo N, Hayashi J.

Intern Med. 2014;53(18):2165-70. Epub 2014 Sep 15.

11.

Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.

Ocama P, Seremba E, Apica B, Opio K.

Afr Health Sci. 2015 Jun;15(2):328-33. doi: 10.4314/ahs.v15i2.4.

12.

Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.

Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A; HepaICONA and the ICONA Study Groups.

Infection. 2009 Oct;37(5):445-9. doi: 10.1007/s15010-008-8194-9. Epub 2009 Aug 7.

PMID:
19669092
13.

Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.

Anggorowati N, Yano Y, Heriyanto DS, Rinonce HT, Utsumi T, Mulya DP, Subronto YW, Hayashi Y.

J Med Virol. 2012 Jun;84(6):857-65. doi: 10.1002/jmv.23293.

PMID:
22499006
14.

An HIV patient with hepatic flare after the initiation of HBV-active antiretroviral therapy.

Yoshida M, Hoshina T, Tamura K, Kawano S, Kato T, Sato F, Nakazawa Y, Yoshikawa K, Onodera S, Hori S.

Intern Med. 2012;51(12):1623-6. Epub 2012 Jun 15.

15.

An evaluation of hepatitis B virus diagnostic methods and responses to antiretroviral therapy among HIV-infected women in Thailand.

Peters PJ, McNicholl JM, Raengsakulrach B, Wasinrapee P, Mueanpai F, Ratanasuwan W, Intalapaporn P, Drobeniuc J, Ramachandran S, Thai H, Xia GL, Kamili S, Khudyakov Y, Weidle PJ, Teo CG, McConnell MS.

J Int Assoc Provid AIDS Care. 2013 Sep-Oct;12(5):349-53. doi: 10.1177/2325957413488201. Epub 2013 Jun 21.

PMID:
23792710
16.

Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan.

Fujisaki S, Yokomaku Y, Shiino T, Koibuchi T, Hattori J, Ibe S, Iwatani Y, Iwamoto A, Shirasaka T, Hamaguchi M, Sugiura W.

J Clin Microbiol. 2011 Mar;49(3):1017-24. doi: 10.1128/JCM.02149-10. Epub 2011 Jan 19. Erratum in: J Clin Microbiol. 2012 Apr;50(4):1507.

17.

Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.

Letang E, Almeida JM, Miró JM, Ayala E, White IE, Carrilho C, Bastos R, Nhampossa T, Menéndez C, Campbell TB, Alonso PL, Naniche D.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):589-97. doi: 10.1097/QAI.0b013e3181bc476f.

PMID:
19801945
18.

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.

Boyd A, Maylin S, Moh R, Mahjoub N, Gabillard D, Eholié SP, Danel C, Anglaret X, Zoulim F, Girard PM, Delaugerre C, Lacombefor K; ANRS 12240 VarBVA study.

J Gastroenterol Hepatol. 2016 Mar;31(3):634-44. doi: 10.1111/jgh.13156.

PMID:
26313291
19.

Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.

Lewin SR, Ribeiro RM, Avihingsanon A, Bowden S, Matthews G, Marks P, Locarnini SA, Ruxrungtham K, Perelson AS, Dore GJ.

Hepatology. 2009 Apr;49(4):1113-21. doi: 10.1002/hep.22754.

20.

Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.

Wang H, Li Y, Zhang C, Han Y, Zhang X, Zhu T, Li T.

AIDS. 2012 Sep 10;26(14):1755-63.

PMID:
22614885

Supplemental Content

Support Center